These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Reducing chemotherapy-associated toxicity in elderly cancer patients. Zagonel V; Fratino L; Sacco C; Babare R; Spazzapan S; Gattei V; Improta S; Pinto A Cancer Treat Rev; 1996 May; 22(3):223-44. PubMed ID: 8841391 [No Abstract] [Full Text] [Related]
8. [Specific adverse events caused by monoclonal antibodies, focusing on the prophylaxis and management]. Akiyama S Nihon Rinsho; 2012 Dec; 70(12):2199-204. PubMed ID: 23259397 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies for medical oncology: a few critical perspectives. Belda-Iniesta C; Ibáñez de Cáceres I; de Castro J Clin Transl Oncol; 2011 Feb; 13(2):84-7. PubMed ID: 21324795 [TBL] [Abstract][Full Text] [Related]
10. Cancer chemotherapy: a guide for nurses. Side-effects of chemotherapy. Thomson L Nurs Times; 1979 Jul; 75(29):Suppl 5-8. PubMed ID: 257437 [No Abstract] [Full Text] [Related]
11. Complications of monoclonal antibody therapy. Meisel K; Rizvi S Med Health R I; 2011 Nov; 94(11):317-9. PubMed ID: 22204093 [No Abstract] [Full Text] [Related]
12. The case of anticipated alopecia. Eisenberg S ONS Connect; 2011 Jul; 26(7):17. PubMed ID: 21877440 [No Abstract] [Full Text] [Related]
13. Antibody-targeted immunotherapy for treatment of malignancy. White CA; Weaver RL; Grillo-López AJ Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771 [TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibody therapy: a literature review]. Del Debbio CB; Tonon LM; Secoli SR Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067 [TBL] [Abstract][Full Text] [Related]
16. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases]. Hansen PB; Hasselbalch HC Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710 [No Abstract] [Full Text] [Related]
17. Immune checkpoint inhibitors for Indian patients: A note of caution. Venniyoor A Indian J Cancer; 2016; 53(3):468-469. PubMed ID: 28244488 [No Abstract] [Full Text] [Related]
18. Anti-Lymphoma Monoclonal Antibodies: Making Better Antibodies and Making Antibodies Better. Weiner GJ Trans Am Clin Climatol Assoc; 2015; 126():87-92. PubMed ID: 26330662 [TBL] [Abstract][Full Text] [Related]
19. Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial. Montemurro F; Redana S; Valabrega G; Martinello R; Aglietta M; Palmiero R J Clin Oncol; 2008 Apr; 26(12):2052-3; author reply 2053-4. PubMed ID: 18421060 [No Abstract] [Full Text] [Related]